Register | Login
World Pharma News .net


The regulators of the multibillion-dollar global drugs industry must sometimes feel like a barnacle on a whale: not easily able to influence the direction of travel. Yesterday's report from the Medicines and Healthcare Products Regulatory Agency (MHRA), on GlaxoSmithKline's failure to disclose adverse evidence about its antidepressant drug Seroxat, reveals again how powerless the watchdog is.

Who Voted for this Story



Enter your email address:

Delivered by FeedBurner